Printer Friendly
The Free Library
14,582,672 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Integrated Biosystems Inc., dated Oct. 11, 2002.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.


Published Date:   Oct. 11, 2002

Company Name:     Integrated Biosystems, Inc.

Address:          445 Devlin Road
                  Napa, CA 94558

Main Telephone
 Number:          707/226-9300

Internet Home
 Page Address
  (URL)           www.integratedbio.com

Chief Executive
 Officer:         John H. Brown

Chief Financial
 Officer:         Jack J. McGovern

Public Relations
 Contact:         Kathryn M. Bowsher
 Business number: 707/226-9300
 E-mail address:  kbowsher@integratedbio.com

Industry:         Biopharmaceutical


Company description: Integrated Biosystems Inc. is the world's leading supplier of controlled Freeze-Thaw technology for biopharmaceutical intermediates and final bulk drug substances. The company was founded in 1996 and is venture funded.

Integrated Biosystems' technology provides the biopharma industry a controlled, validated val·i·date  
tr.v. val·i·dat·ed, val·i·dat·ing, val·i·dates
1. To declare or make legally valid.

2. To mark with an indication of official sanction.

3.
 way to freeze See abend.

freeze - To lock an evolving software distribution or document against changes so it can be released with some hope of stability. Carries the strong implication that the item in question will "unfreeze" at some future date.
 and then thaw biopharmaceutical products in a consistent, reproducible re·pro·duce  
v. re·pro·duced, re·pro·duc·ing, re·pro·duc·es

v.tr.
1. To produce a counterpart, image, or copy of.

2. Biology To generate (offspring) by sexual or asexual means.
 manner. Freezing freezing, change of a substance from the liquid to the solid state. The temperature at which freezing occurs for a pure crystalline solid is called the freezing point and is a characteristic of the particular substance.  provides a stable hold step that de-couples the manufacturing steps from each other. Since biopharmaceutical manufacturing capacity is a big issue, the ability to un-couple one step from the next allows the process to be optimized at each step and also allows inventory to be held at a level that's most economical.

The technology was developed at Genentech Genentech Inc. (NYSE: DNA), a composite of Genetic Engineering Technology, Inc., is a leading biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer.  in the late 1980s. Integrated BioSystems' Freeze-Thaw technology has been used for over 10 years at leading biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 and biopharma manufacturers. To date, over $5 billion worth of commercial product has been processed with this technology.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 11, 2002
Words:252
Previous Article:Corporate Profile for Worthmore, Inc., dated Oct. 11, 2002.
Next Article:Atmel Provides Preliminary Third Quarter 2002 Results.



Related Articles
APPLIED BIOSYSTEMS/MILLIPORE FUND UNIV. OF TOKYO PROTEOMICS.
Applied Biosystems and Myriad Proteomics Announce Research Collaboration to Develop Technologies and Applications for Proteomics.
Applied Biosystems to Introduce New Protein Expression Analysis Technology At 5th Biannual Siena Proteomics Meeting.
Applied Biosystems Receives Adverse Jury Verdict Relating to Discontinued Operations.
Integrated Biosystems, Inc. and STEDIM S.A. Announce Agreement.
Applied Biosystems Group and Celera Genomics Group First Quarter FY 2003 Financial Results and Conference Call Scheduled For October 24, 2002.
Applied Biosystems, HTS Biosystems and Mitsubishi Chemical Corporation Announce Distribution Agreement in Japan and Collaboration for Next-Generation...
Celera Diagnostics Announces Research Collaboration with Merck.
Applied Biosystems Announces Worldwide Commercial Availability of the Expression Array System.
Applied Biosystems Introduces New, Integrated System Designed to Improve Gene Expression Analyses Involving Whole Blood Samples.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles